Bayer has inaugurated its state-of-the-art laboratory dedicated to advancing innovation in phytomedicines and biotics, including the renowned Iberogast. This milestone marks a significant investment in Bayer’s commitment to delivering natural health solutions to consumers worldwide and underlines Bayer’s commitment at the Darmstadt site.

“This new lab is a game changer for our business and our team,” said Chloe Picot, site lead at Darmstadt. “It gives our world-class team in-house prototyping capabilities, allowing us to innovate more efficiently and quickly.”

The new facility will serve as a hub for research and development to enable continued innovation of Iberogast and other plant-based and biotic solutions, enabling rapid prototyping of new formulations and fostering collaboration among teams.

Thorsten Umland, head of digestive health research and development at Bayer added, “This facility is a testament to Bayer’s commitment to meeting the growing demand for natural health solutions, building on a 60-year legacy of leadership in phytomedicines. The lab will facilitate the development of herbal and natural-based solutions that are validated by science and trusted by consumers, ensuring that Bayer remains at the forefront of phytomedicine innovation”.